Fortunato Ciardiello

机构：University of Campania "Luigi Vanvitelli", University of Campania "Luigi Vanvitelli", Azienda Ospedaliera Universitaria Università degli Studi della Campania Luigi Vanvitelli · ORCID：0000-0002-3369-4841

发表论文 1038 篇 · 总被引 65551 次 · h-index 108

代表论文

• Encorafenib, Cetuximab, and mFOLFOX6 in BRAF -Mutated Colorectal Cancer (2025 · New England Journal of Medicine · 被引 144)
• TGF-β Modulated Pathways in Colorectal Cancer: New Potential Therapeutic Opportunities (2024 · International Journal of Molecular Sciences · 被引 55)
• Atezolizumab plus bevacizumab as first-line treatment of unresectable hepatocellular carcinoma: interim analysis results from the phase IIIb AMETHISTA trial (2025 · ESMO Open · 被引 18)
• PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer (2024 · Biomedicines · 被引 17)
• Impact of KRASG12 mutations on survival with trifluridine/tipiracil plus bevacizumab in patients with refractory metastatic colorectal cancer: post hoc analysis of the phase III SUNLIGHT trial (2024 · ESMO Open · 被引 16)
• Tisotumab vedotin in head and neck squamous cell carcinoma: Updated analysis from innovaTV 207 Part C. (2024 · Journal of Clinical Oncology · 被引 15)